Table 3.
Univariate analysis and multivariate logistic regression assessing risk factors for transient bradycardia
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Female sex | 3.467 (0.969–12.398) | .056 | 3.655 (0.708–18.876) | .122 |
| Age > 65 years | 5 (1.393–17.943) | .014 | 18.618 (2.339–148.171) | .006 |
| CVD | 0.923 (0.281–3.034) | .895 | 9.472 (0.779–115.107) | .078 |
| Beta‐blockers | 2.368 (0.544–10.317) | .251 | 2.119 (0.232–19.384) | .506 |
| T ≥ 38°C | 3.714 (0.604–22.867) | .157 | ||
| Lymphocytes < 800/mm3 | 0.773 (0.224–2.668) | .683 | ||
| C‐RP > 5 mg/dl | 3.467 (0.969–12.398) | .056 | 2.973 (0.449–19.665) | .258 |
| D‐dimer > 1000 ng/ml | 0.7 (0.19–2.58) | .592 | ||
| RDV therapy | 5 (1.393–17.943) | .014 | 6.915 (1.007–47.499) | .049 |
| PaO2/FiO2 < 300 | 2.057 (0.575–7.364) | .268 | ||
Note: Bold values indicate statistically significant values.
Abbreviations: CI, confidential interval; C‐RP, C‐reactive protein; CVD, cardiovascular diseases, OR, odds ratio; RDV, remdesivir; T, temperature.